4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-035893
Chief Commercial Officer sold 36,592 shares at $8.20 ($299,904)
From the SEC's structured data for this filing
Trades in this filing
VAN BEEK JEROEN B · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-11 | Sale : show line 1 in the form | −36,592 | $8.20 | $299,904 | 349,800 | D |
| Open-market sales · 36,592 sh · avg $8.20 · $299,904 | ||||||
Loading xslF345X03/doc4.xml…